What a Second Trump Term Means for Antitrust Enforcement

By Raymond A. Jacobsen, Jr., Jon B. Dubrow, Joel R. Grosberg and Royce Brosseau on December 4, 2024

Posted In DOJ Developments, FTC Developments, Healthcare Antitrust, IP Antitrust, Mergers & Acquisitions, Monopolization/Abuse of Dominance

On January 20, 2025, President-elect Donald J. Trump’s administration will come into power. The McDermott antitrust and competition team has analyzed the first Trump term, compared it to the Biden administration’s actions, and reviewed statements from those involved in the upcoming Trump administration. While it appears that the new administration will be good for business, especially for companies planning to expand through mergers and acquisitions, this client alert takes a closer look at what is likely to change and what is likely to stay the same in antitrust enforcement throughout the next four years.

Tags: 2015 Policy Statement, 2022 Policy Statement, 2023 Merger Guidelines, Biden administration, Big Tech, DOJ, Federal Trade Commission, FTC, FTC Act Section 5, Hart-Scott-Rodino (HSR) Act, President-elect Donald Trump, Project 2025, Sherman Act, Trump administration, US Department of Justice

Raymond A. Jacobsen, Jr.
Raymond (Ray) A. Jacobsen, Jr., advises clients on mergers, acquisitions and complex antitrust litigation. He has significant experience in the defense, medical devices, biotech, consumer product, energy and health care industries. Ray heads McDermott’s Antitrust Practice. Read Raymond A. Jacobsen, Jr.'s full bio.

Jon B. Dubrow
Jon Dubrow is co-head of McDermott’s Antitrust Mergers Focus Group and is a strategic advisor serving clients across a host of inter-related antitrust issues, including mergers and acquisitions (M&A) transactions / merger clearance, counseling and litigation. Jon leads the defense of mergers, acquisitions and joint ventures before the Department of Justice, the Federal Trade Commission and other international competition authorities. He also regularly assists third parties whose interests are adversely affected by proposed transactions. Jon also is experienced in antitrust litigation. He provides counseling on distribution issues, contracting arrangements and a wide variety of other competition-related matters. Read Jon Dubrow's full bio.

Joel R. Grosberg
Joel R. Grosberg is co-head of McDermott’s Antitrust Mergers Focus Group and assists clients on civil and criminal antitrust matters, including obtaining merger clearances, counseling and litigation. He has represented clients in obtaining antitrust approvals in numerous challenging transactions, and in other government antitrust investigations before the Department of Justice, the Federal Trade Commission (“FTC”) and foreign competition authorities. Joel has significant experience in the high tech, chemical, health care and life sciences industries, including counseling on matters related to pricing and distribution practices and other competition-related issues. Read Joel Grosberg's full bio.

Royce Brosseau
Royce E. Brosseau focuses his practice on antitrust, regulatory, and litigation matters. Read Royce Brosseau's full bio.

What a Second Trump Term Means for Antitrust Enforcement

Related Posts

BLOG EDITORS

STAY CONNECTED

TOPICS

ARCHIVES

RECENT POSTS